Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
Authors
Keywords
-
Journal
CANCER
Volume 118, Issue 10, Pages 2603-2614
Publisher
Wiley
Online
2011-10-06
DOI
10.1002/cncr.26565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available
- (2011) V. Abramson et al. CLINICAL CANCER RESEARCH
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- (2010) Helen M. Heneghan et al. ANNALS OF SURGERY
- Reprogramming of miRNA networks in cancer and leukemia
- (2010) S. Volinia et al. GENOME RESEARCH
- MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)
- (2010) Soken Tsuchiya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of MicroRNAs in Cardiac Preconditioning
- (2010) Fadi N Salloum et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
- (2009) E. A. Mathe et al. CLINICAL CANCER RESEARCH
- MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
- (2009) J. Li et al. CLINICAL CANCER RESEARCH
- The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy
- (2009) Katie DeClerck Frontiers in Bioscience-Landmark
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
- (2009) Thomas Greither et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
- (2008) Charles H. Lawrie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
- (2008) Matthew E. Hardee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
- (2008) C. Camps et al. CLINICAL CANCER RESEARCH
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- Hypoxia response and microRNAs: no longer two separate worlds
- (2008) Mircea Ivan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
- Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
- (2008) J. A. Foekens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started